Skip to main content
. 2016 Apr 12;9(2):114–123. doi: 10.1016/j.tranon.2016.01.001

Table 1.

Biomarker Distribution in the Final Patient Cohort (58 Patients)

Biomarker Number Percent
PI3K hotspot mutations Wild 17 70.2%
Mutant 7 29.2%
Missing 34
Nuclear LKB1 Low 11 34.4%
High 21 65.6%
Missing 26
Cytoplasmic LKB1 Low 12 37.5%
High 20 62.5%
Missing 26
Nuclear pAKT Low 12 37.5%
High 20 62.5%
Missing 26
Cytoplasmic pAKT Low 10 31.2%
High 22 68.8%
Missing 26
P4EBP1 Low 19 57.6%
High 14 42.4%
Missing 25
pS6RP Low 14 42.2%
High 19 57.6%
Missing 25